Clinical study offer

🎗️ Paid Liver Cancer Clinical Trials

Browse recruiting liver cancer clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Liver Cancer
Condition

Active Clinical Trials for Liver Cancer

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Liver Cancer

Liver cancer is a serious malignancy often developing in the setting of chronic liver disease. Clinical trials explore tyrosine kinase inhibitors, immune checkpoint inhibitors, locoregional therapies, and combination approaches for hepatocellular carcinoma.

Common Symptoms

Unexplained weight loss, loss of appetite, upper abdominal pain, nausea and vomiting, jaundice, enlarged liver, white or chalky stools, fatigue

Risk Factors

Chronic hepatitis B or C, cirrhosis, excessive alcohol consumption, nonalcoholic fatty liver disease, diabetes, obesity, aflatoxin exposure, hemochromatosis

Treatment Overview

Treatment includes surgery, ablation, embolization, targeted therapy, and immunotherapy. Clinical trials study novel combinations and immunotherapies for improved outcomes.

Why Participate?

Liver cancer clinical trials provide access to innovative targeted and immunotherapeutic agents for this challenging disease.

Related Conditions

States with Liver Cancer Clinical Trials

Cities with Liver Cancer Clinical Trials

Frequently Asked Questions About Liver Cancer Clinical Trials

Liver Cancer clinical trials are research studies that test new treatments, medications, devices, or interventions for managing or treating liver cancer. They help determine the safety and effectiveness of potential new approaches.
Eligibility varies by study. Factors include the type and severity of liver cancer, age, overall health status, and prior treatment history. Each study has specific inclusion and exclusion criteria.
Compensation depends on the study duration, number of visits, and procedures involved. Participants may receive payments ranging from $50 to $300 per visit, with total compensation varying by study.
All clinical trials follow strict safety protocols and are reviewed by Institutional Review Boards (IRBs) to protect participants. Potential risks are explained during the informed consent process before enrollment.